1 - 10 out of 10Page size: 10
  1. 2022

  2. A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike

    van der Velden, Y. U., Grobben, M., Caniels, T. G., Burger, J. A., Poniman, M., Oomen, M., Rijnstra, E. S., Tejjani, K., Guerra, D., Kempers, R., Stegmann, T., van Gils, M. J. & Sanders, R. W., 1 Dec 2022, In: Scientific reports. 12, 1, 3884.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection

    Lavell, A. H. A., Sikkens, J. J., Edridge, A. W. D., van der Straten, K., Sechan, F., Oomen, M., Buis, D. T. P., Schinkel, M., Burger, J. A., Poniman, M., van Rijswijk, J., de Jong, M. D., de Bree, G. J., Peters, E. J. G., Smulders, Y. M., Sanders, R. W., van Gils, M. J., van der Hoek, L. & Bomers, M. K., 21 Oct 2022, In: iScience. 25, 10, 105105.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study

    van Gils, M. J., Lavell, A., van der Straten, K., Appelman, B., Bontjer, I., Poniman, M., Burger, J. A., Oomen, M., Bouhuijs, J. H., van Vught, L. A., Slim, M. A., Schinkel, M., Wynberg, E., van Willigen, H. D. G., Grobben, M., Tejjani, K., van Rijswijk, J., Snitselaar, J. L., Caniels, T. G., Vlaar, A. P. J., & 6 othersPrins, M., de Jong, M. D., de Bree, G. J., Sikkens, J. J., Bomers, M. K. & Sanders, R. W., 1 May 2022, In: PLoS medicine. 19, 5, e1003991.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands

    Juncker, H. G., Mulleners, S. J., Ruhé, E. J. M., Coenen, E. R. M., Bakker, S., van Doesburg, M., Harinck, J. E., Rood, R. D., Bouhuijs, J. H., Oomen, M., de Groot, P. C. J. M., Pajkrt, P. D., Korosi, A., van Goudoever, P. J. B., van Gils, M. J. & van Keulen, B. J., 1 May 2022, In: EClinicalMedicine. 47, 101393.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

    van Gils, M. J., van Willigen, H. D. G., Wynberg, E., Han, A. X., van der Straten, K., Burger, J. A., Poniman, M., Oomen, M., Tejjani, K., Bouhuijs, J. H., Verveen, A., Lebbink, R., Dijkstra, M., Appelman, B., Lavell, A. H. A., Caniels, T. G., Bontjer, I., van Vught, L. A., Vlaar, A. P. J., Sikkens, J. J., & 32 othersBomers, M. K., Russell, C. A., Kootstra, N. A., Sanders, R. W., Prins, M., de Bree, G. J., de Jong, M. D., RECoVERED Study Group, Agard, I., Ayal, J., Boyd, A., Cavdar, F., Craanen, M., Davidovich, U., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., Hartman, J., Koedoot, N., van den Aardweg, J., Boeser-Nunnink, B., Moll van Charante, E., van Dort, K., Hidad, S., Jurriaans, S., Knoop, H., Lok, A., Maurer, I., Nieuwkerk, P., van Nuenen, A. & Matser, A., 18 Jan 2022, In: Cell Reports Medicine. 3, 1, 100486.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2021

  8. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern

    Brinkkemper, M., Brouwer, P. J. M., Maisonnasse, P., Grobben, M., Caniels, T. G., Poniman, M., Burger, J. A., Bontjer, I., Oomen, M., Bouhuijs, J. H., van der Linden, C. A., Villaudy, J., van der Velden, Y. U., Sliepen, K., van Gils, M. J., le Grand, R. & Sanders, R. W., 1 Dec 2021, In: npj Vaccines. 6, 1, 146.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

    Amsterdam UMC COVID-19 S3/HCW study group, 23 Nov 2021, In: eLife. 10, e70330.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Saliva SARS-CoV-2 antibody prevalence in children

    Keuning, M. W., Grobben, M., de Groen, A-E. C., Berman-de Jong, E. P., Bijlsma, M. W., Cohen, S., Felderhof, M., de Groof, F., Molanus, D., Oeij, N., Rijpert, M., van Eijk, H. W. M., Koen, G., van der Straten, K., Oomen, M., Visser, R., Linty, F., Steenhuis, M., Vidarsson, G., Rispens, T., & 3 othersPlötz, F. B., van Gils, M. J. & Pajkrt, D., 1 Oct 2021, In: Microbiology spectrum. 9, 2, e00731-21.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

    Amsterdam UMC COVID-19 S3/HCW study group, 1 Oct 2021, In: EBioMedicine. 72, 103589.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination

    Caniels, T. G., Bontjer, I., van der Straten, K., Poniman, M., Burger, J. A., Appelman, B., Lavell, H. A. A., Oomen, M., Godeke, G-J., Valle, C., Mögling, R., van Willigen, H. D. G., Wynberg, E., Schinkel, M., van Vught, L. A., Guerra, D., Snitselaar, J. L., Amsterdam UMC COVID-19 S3/HCW study group, Chaturbhuj, D. N., Martin, I. C., & 9 othersMoore, J. P., de Jong, M. D., Reusken, C., Sikkens, J. J., Bomers, M. K., de Bree, G. J., van Gils, M. J., Eggink, D. & Sanders, R. W., 1 Sept 2021, In: Science advances. 7, 36, p. eabj5365 eabj5365.

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 13454998